Breast cancer is a heterogeneous disease and is generally classified into three subtypes according to receptor expression: estrogen and progesterone receptor positive (ER + /PR +), human epidermal growth factor receptor positive (HER2 +), and triple negative (ER-/PR- /HER2 −). This evidence concerns the gene ERBB2 and breast carcinoma.